Now showing items 1-10 of 26
Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D
Background/aims: Liver biopsy to assess fibrosis is invasive and prone to sampling error. While algorithms of serum markers to predict fibrosis stage have been described for chronic hepatitis C, these cannot be applied ...
Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
Background/aims: Owing to its high efficacy, ease of use, perfect adaptation and low complication profile, it is suggested that the triple therapy combination consisting of levofloxacin, amoxicillin and proton pump inhibitor ...
Effectiveness of different treatment regimens in helicobacter pylori eradication: Ten-year experience of a single institution
Aim: We aimed to report the outcomes of different H. pylori eradication regimens used in our institution over the last 10 years. Method: Retrospectively, H. pylori-positive patients who were referred for upper gastrointestinal ...
Endoscopic treatment of biliary complications following liver transplantation
Background/Aims: The aims of the present study were to review biliary complications following liver transplantation in a single-center experience, to identify the factors associated with biliary complications, and to ...
The efficacy and safety of colonoscopy preparation with oral sodium phosphate in elderly patients
Background/aims: Oral sodium phosphate is an agent used commonly in our country for cleaning the intestines before colonoscopy. Our aim was to compare the safety, tolerability and efficiency of oral sodium phosphate solution ...
Long-term outcomes associated with pancreatic extracorporeal shock wave lithotripsy for chronic calcific pancreatitis
Background: Most outcomes data on pancreatic extracorporeal shock wave lithotripsy (P-ESWL) for chronic calcific pancreatitis (CCP) are based on studies with < 4 years- follow-up, and U.S. long-term studies are lacking.
CLEVUDINE TREATMENT OF CHRONIC DELTA HEPATITIS